Sidley lawyers Deeona Gaskin and Raj Pai recently published an article in Cell & Gene entitled “Manufacturing CGTs: Should I Use A CDMO?” The article explains various manufacturing challenges faced by sponsors of cell and gene therapies, and considerations for companies looking to outsource manufacturing of their cell and gene therapy products to contract manufacturing organizations (CMOs) or contract development and manufacturing organizations (CDMOs).
Cell & Gene
Manufacturing CGTs: Should I Use A CDMO?
September 30, 2022
Contacts
Related Resources
BLOGS
Related Capabilities
SERVICES AND INDUSTRIES
Stay Up To Date